FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2561576092> ?p ?o ?g. }

• W2561576092 endingPage "85" @default.
• W2561576092 startingPage "73" @default.
• W2561576092 abstract "Irinotecan is used clinically for the treatment of colorectal cancer; however, its utility is limited by its narrow therapeutic index. We describe the use of a generation 5 l-lysine dendrimer that has been part-modified with a polyoxazoline as a drug delivery vehicle for improving the therapeutic index of SN-38, the active metabolite of irinotecan. By conjugating SN-38 to the dendrimer via different linker technologies we sought to vary the release rate of the drug to generate diverse pharmacokinetic profiles. Three conjugates with plasma release half-lives of 2.5 h, 21 h, and 72 h were tested for efficacy and toxicity using a mouse SW620 xenograft model. In this model, the linker with a plasma release half-life of 21 h achieved sustained SN-38 exposure in blood, above the target concentration. Control over the release rate of the drug from the linker, combined with prolonged circulation of the dendrimer, enabled administration of an efficacious dose of SN-38, achieving significant regression of the SW620 tumours. The conjugates with 2.5 and 72 h release half-lives did not achieve an anti-tumour effect. Intraperitoneal dosing of the clinically used prodrug irinotecan produces high initial and local concentrations of SN-38, which are associated with gastrointestinal toxicity. Administration of the 21 h release dendrimer conjugate did not produce a high initial Cmax of SN-38. Consequently, a marked reduction in gastrointestinal toxicity was observed relative to irinotecan treatment. Additional studies investigating the dose concentrations and dose scheduling showed that a weekly dosing schedule of 4 mg SN-38/kg was the most efficacious regimen. After 4 doses at weekly intervals, the survival period of the mice extended beyond 70 days following the final dose. These extensive studies have allowed us to identify a linker, dose and dosing regimen for SN-38 conjugated to polyoxazoline-modified dendrimer that maximised efficacy and minimised adverse side effects." @default.
• W2561576092 created "2017-01-06" @default.
• W2561576092 creator A5008074351 @default.
• W2561576092 creator A5015211752 @default.
• W2561576092 creator A5020325554 @default.
• W2561576092 creator A5024704112 @default.
• W2561576092 creator A5044054725 @default.
• W2561576092 creator A5045598309 @default.
• W2561576092 creator A5061346222 @default.
• W2561576092 creator A5062588787 @default.
• W2561576092 creator A5063837282 @default.
• W2561576092 creator A5084595261 @default.
• W2561576092 creator A5091194683 @default.
• W2561576092 date "2017-02-01" @default.
• W2561576092 modified "2023-10-03" @default.
• W2561576092 title "Tumour regression and improved gastrointestinal tolerability from controlled release of SN-38 from novel polyoxazoline-modified dendrimers" @default.
• W2561576092 cites W1879356743 @default.
• W2561576092 cites W1967105697 @default.
• W2561576092 cites W1981116681 @default.
• W2561576092 cites W1982518352 @default.
• W2561576092 cites W1985111504 @default.
• W2561576092 cites W1990128204 @default.
• W2561576092 cites W1995742898 @default.
• W2561576092 cites W1996720815 @default.
• W2561576092 cites W2000941201 @default.
• W2561576092 cites W2008162040 @default.
• W2561576092 cites W2014014132 @default.
• W2561576092 cites W2017919162 @default.
• W2561576092 cites W2028745823 @default.
• W2561576092 cites W2047702121 @default.
• W2561576092 cites W2051992129 @default.
• W2561576092 cites W2053422722 @default.
• W2561576092 cites W2057274478 @default.
• W2561576092 cites W2057652593 @default.
• W2561576092 cites W2065680956 @default.
• W2561576092 cites W2073676974 @default.
• W2561576092 cites W2075247874 @default.
• W2561576092 cites W2075659348 @default.
• W2561576092 cites W2083710155 @default.
• W2561576092 cites W2084640406 @default.
• W2561576092 cites W2087414776 @default.
• W2561576092 cites W2092938559 @default.
• W2561576092 cites W2095122176 @default.
• W2561576092 cites W2102453083 @default.
• W2561576092 cites W2103272654 @default.
• W2561576092 cites W2107838011 @default.
• W2561576092 cites W2116419043 @default.
• W2561576092 cites W2117786997 @default.
• W2561576092 cites W2150525477 @default.
• W2561576092 cites W2151477149 @default.
• W2561576092 cites W2154908899 @default.
• W2561576092 cites W2155164563 @default.
• W2561576092 cites W2156123663 @default.
• W2561576092 cites W2156440914 @default.
• W2561576092 cites W2157354264 @default.
• W2561576092 cites W2192049920 @default.
• W2561576092 cites W2196236965 @default.
• W2561576092 cites W2278083835 @default.
• W2561576092 cites W2285408387 @default.
• W2561576092 cites W2306899626 @default.
• W2561576092 cites W2327486849 @default.
• W2561576092 cites W2336248425 @default.
• W2561576092 cites W2336792134 @default.
• W2561576092 cites W2397040753 @default.
• W2561576092 cites W2409322723 @default.
• W2561576092 cites W2415245575 @default.
• W2561576092 cites W2554773181 @default.
• W2561576092 doi "https://doi.org/10.1016/j.jconrel.2016.12.034" @default.
• W2561576092 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28043863" @default.
• W2561576092 hasPublicationYear "2017" @default.
• W2561576092 type Work @default.
• W2561576092 sameAs 2561576092 @default.
• W2561576092 citedByCount "26" @default.
• W2561576092 countsByYear W25615760922017 @default.
• W2561576092 countsByYear W25615760922018 @default.
• W2561576092 countsByYear W25615760922019 @default.
• W2561576092 countsByYear W25615760922020 @default.
• W2561576092 countsByYear W25615760922021 @default.
• W2561576092 countsByYear W25615760922022 @default.
• W2561576092 countsByYear W25615760922023 @default.
• W2561576092 crossrefType "journal-article" @default.
• W2561576092 hasAuthorship W2561576092A5008074351 @default.
• W2561576092 hasAuthorship W2561576092A5015211752 @default.
• W2561576092 hasAuthorship W2561576092A5020325554 @default.
• W2561576092 hasAuthorship W2561576092A5024704112 @default.
• W2561576092 hasAuthorship W2561576092A5044054725 @default.
• W2561576092 hasAuthorship W2561576092A5045598309 @default.
• W2561576092 hasAuthorship W2561576092A5061346222 @default.
• W2561576092 hasAuthorship W2561576092A5062588787 @default.
• W2561576092 hasAuthorship W2561576092A5063837282 @default.
• W2561576092 hasAuthorship W2561576092A5084595261 @default.
• W2561576092 hasAuthorship W2561576092A5091194683 @default.
• W2561576092 hasBestOaLocation W25615760922 @default.
• W2561576092 hasConcept C108215921 @default.
• W2561576092 hasConcept C111919701 @default.
• W2561576092 hasConcept C112705442 @default.
• W2561576092 hasConcept C121608353 @default.
• W2561576092 hasConcept C126322002 @default.

• next